Startup Company for Artificial Intelligence in the area of Drug Discovery

Who are we?

We aim at the healthy life of human being. 

We pursue for people to benefit from the new drugs.

We focus on artificial intelligence that accelerates the development of new drugs

that treat various diseases especially including rare diseases.

Multi-omics based whole-body simulation
New Drug development costs
Economy of a new drug
New Drug development period
New drug benefits




YoungWoo Pae, Ph.D.

Co-Founder, Chief Executive Officer

Former IBM Executive for Watson

Expert Council, KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association)

JungWoo Woo

Software Engineer

Seung-Hyun Jin, Ph.D.

Co-Founder, Chief Science Officer

Ph.D. in Physics, KAIST

Former Assistant Professor, Seoul National University Hospital

HyeongHwan Kim

Software Engineer

HeungSoo Kim, Ph.D.

Director of Business Leader

Former industry-academy cooperation professor, Chungnam National Uni.

SeungHyeon Choi

Data Scientist


SeongGyu Kim

Data Scientist

Chemical&Biological Engineering​


Young Gyu Cho, Ph.D.

Executive Vice President /  CTO

GI Innovation
Ph.D. in Life Science, POSTECH

Former Director of Research, HANDOK



Contact us

Tel: 02-890-0779

Fax: 02-890-0780

#803, ​8F, Mario Tower, 28, Digital-ro 30-gil, Guro-gu, Seoul, Republic of Korea


​Guro Digital Complex Station EXIT 3, Walk for 8 minutes